RSS
|
Login
|
Register
Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Issue Archive
Events
Awards
Webcasts
Surveys
Directories
PMD
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
Approval Articles
Product news
October 11, 2007
Boehringer Ingelheim Pharmaceuticals announced that the FDA has granted full approval of Aptivus (tipranavir) capsules.
Product news
September 27, 2007
Sanofi-Aventis and Bristol-Myers Squibb said the FDA Administration has approved a supplemental new drug application for a 300 mg tablet of the antiplatelet drug Plavix (clopidogrel bisulfate).
Product news
September 25, 2007
GlaxoSmithKline announced that the European Commission has granted a marketing authorization for its cervical cancer vaccine, Cervarix, for all 27 European member states.
AZ/MedImmune's FluMist gets big boost with new indication
Matthew Arnold
September 19, 2007
MedImmune announced that the FDA has approved the use of its FluMist in children 2-5 years old, an indication that significantly expands the market for the nasal vaccine.
Product news
September 18, 2007
The FDA approved Eli Lillys osteoporosis drug Evista to reduce breast cancer risk in some postmenopausal women.
Product news
September 11, 2007
Quinnova Pharmaceuticals announced the commercial launch of Tersi Foam, (2.25% selenium sulfide) for the treatment of seborrheic dermatitis and tinea versicolor of the skin.
FDA approves new vaccine for smallpox
Stephen McGuire
September 04, 2007
The FDA has approved a new vaccine against smallpox which could be quickly made if the virtually extinct virus were to reappear.
Product news
September 04, 2007
The FDA has approved Evithrom (human thrombin), a blood-clotting protein used to help control bleeding during surgery.
New approval for drug gives Novartis excuse to up promotion
August 20, 2007
The newest indication for Reclast -- postmenopausal osteoporosis -- ups its market potential considerably, analysts said.
Key advisor: FDA should hold diabetes drugs to different standard
Marc Iskowitz
August 09, 2007
In an opinion piece yesterday, the chair of the FDA advisory committee on Avandia recommended the agency change the way it evaluates experimental diabetes drugs.
« Previous
Next »
Most Popular
Thomson Reuters names five most promising Q1 drugs
Pharma donors favor Obama
Manhattan Research names top product sites for docs
Harry and Louise having second thoughts on healthcare
UCB cuts 2,000 jobs, re-tools as a specialty company
Stanford prohibits direct commercial CME sponsorship
GSK to make grant info public
Vioxx trial described as marketing stunt
Medical Economics overhauls editorial team
AMM honors top journal ads
Most Emailed
The End of CME as We Know It
Abbott launches Crohn's disease podcasts
Verispan acquired by data rival SDI
AstraZeneca teams up with Abbott on Crestor co-promote
'Fully Engaged' docs more open to influence
UCB cuts 2,000 jobs, re-tools as a specialty company
Stanford prohibits direct commercial CME sponsorship
Surprise! Massachusetts gift ban is back
Changing Channels
Manhattan Research names top product sites for docs
Most Recent
Amgen to unbundle anemia medications
UCB cuts 2,000 jobs, re-tools as a specialty company
GfK drops TNS bid
Stanford prohibits direct commercial CME sponsorship
Manhattan Research names top product sites for docs
Medical Economics overhauls editorial team
GSK to make grant info public
AMM honors top journal ads
Vioxx trial described as marketing stunt
Harry and Louise having second thoughts on healthcare
Popular Tags
Advertising
Agency
Approval
Awards
Biotech
Brand
Clinical trial
Continuing medical education (CME)
Education & Awareness
FDA
Government
Launch
Legal
Magazine
Marketing & Communications
Marketing Research
Media
New hire
Online
Pharmaceutical
Pipeline
Product
Professional
Promotion
Regulatory
Home
|
News
|
Features
|
Events
|
Surveys
|
Lists
|
Directories
|
Jobs
|
About Us
|
Contact Us
|
Subscribe
|
Newsletters
|
PMD
|
Advertise
|
Editorial Advisory Board
|
RSS